@FierceBiotech: #1 biotech billionaire on our list? @BillGates | Full report | Follow @FierceBiotech
@JohnCFierce: The biotech gods taketh away, and they giveth. Regeneron expanding, adding 400 jobs. More | Follow @JohnCFierce.
@RyanMFierce: Pfizer made another early-stage deal with a Cambridge, MA biotech. This one with Gates-backed Tetragenics. Release | Follow @RyanMFierce
> Investigators slammed the brakes on a Phase I study combining Yervoy and Zelboraf after four of the 6 patients in the trial experienced liver toxicity after taking the first two drugs approved for melanoma. "Our findings reinforce the need for carefully conducted trials of new combination therapies, even when both agents have regulatory approval and have distinct mechanisms of action," the researchers noted. Story
> Navidea ($NAVB) says that its imaging agent Lymphoseek successfully identified lymph node cancer in 38 of 39 patients with head and neck cancer whose cancer had spread. The study will help the company make its case for widening use of the agent for all solid cancers. Story
> Roche ($RHHBY) has launched Elecsys Calcitonin, a new lab test for the diagnosis and lifelong monitoring of medullary thyroid cancer patients after thyroid surgery. Release
> VaxInnate has won a $2.2 million grant from the National Institute of Allergy and Infectious Diseases to fund the development of a recombinant vaccine to guard against dengue. Release
Pharma News
@FiercePharma: Analysts expect nanotech drug delivery boom despite safety concerns. Article | Follow @FiercePharma
@EricPFierce: Pfizer recalls 52,000 bottles of its thyroid pill Levoxyl because of a bad odor. More | Follow @EricPFierce
> Big Pharma shows its claws with new compensation policies. Article
> Novartis aims new Gilenya campaign at young MS patients. Report
> Pfizer fails to block $142M Neurontin award, faces 2 more suits. Story
Pharma Manufacturing News
> Industry ready to resurrect track and trace negotiations. Report
> Pfizer has another recall tied to smelly drugs. More
> Canada compounding pharmacy linked to weak chemo drugs. Story
> Frazier grabs AndersonBrecon as it bulks up in packaging. Article
Vaccines News
> JAMA paper delves into Merck staph vaccine flunk. Item
> Text message campaign fails to boost vaccination rate. Article
> U.S. keeping rubella at bay as virus takes toll globally. More
> Autism argument again undermined by vaccine data. Story
> Merck vax condemning pox to past. Report
@FierceMedDev: Dako gains FDA blessing for breast cancer antibody Dx agent. More | Follow @FierceMedDev
@MarkHFierce: Japan is dropping reimbursement rates for interventional cardiology devices. Not a good development for business. Story | Follow @MarkHFierce
@DamianFierce: Bausch + Lomb has a date with the FDA for its intraocular lens implant. Article | Follow @DamianFierce
> New Dx chip allows for liquid diagnosis of prostate cancer advance. More
> Roche rolls out thyroid cancer Dx. Story
> Navidea touts PhIII data on Lymphoseek for head and neck cancer. Article
And Finally... A new strain of bird flu--H7N9--has killed a third person in China, raising fears that the lethal flu has mutated, making it easier to spread from animals to humans. Story